Startup Scout 29 Sep 2022 Baseimmune makes future-proof vaccines with AI Baseimmune is using artificial intelligence (AI) to design vaccines that can protect against future variants of infectious diseases including COVID-19 and malaria. Big data has taken off in the last… September 29, 2022 - 6 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 19 Sep 2016 How Tech Transfer brings Science from the Bench to the Bedside There are so many exciting discoveries in scientific research that could be used to cure, feed and fuel the world, but there is a giant gulf between science and business…. September 19, 2016 - 6 minutesmins - By Marie Godar Share WhatsApp Twitter Linkedin Email
News and Trends 28 Oct 2016 TCR and Checkpoint inhibitors: A Match made in Heaven for Blood Cancer Adaptimmune and MSD are collaborating to test a therapy for multiple myeloma that combines some of the most promising technologies in immuno-oncology: TCR and checkpoint inhibitors. Adaptimmune is an immuno-oncology… October 28, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 15 Nov 2017 New British Biotech Receives £3M to Develop Small Molecules that Fight Cancer NeoPhore, has received investment from Sixth Element Capital to develop small molecules that stimulate the immune system against cancer. Sixth Element Capital has invested £3M (€3.3M) in NeoPhore, a new… November 15, 2017 - 1 minutemin - By Alex Dale Share WhatsApp Twitter Linkedin Email
More News! 4 Feb 2017 This PhD-Carrying Musician Tells the Story of Life through Music & Video Max Cooper bridges the age-old divide between science and art with a transfixing blend of glitchy electronica, classical music and haunting vocals. I was lucky enough to catch Max Cooper… February 4, 2017 - 6 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 19 Oct 2022 Nucleome Therapeutics raises £37.5M to deliver precision medicines U.K. biotech company Nucleome Therapeutics Limited has closed an oversubscribed £37.5 million ($42.4 million) series A financing round. The funds will be used to advance the company’s autoimmune disease programs,… October 19, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Interview 24 Jan 2023 Watch: Queen’s University tackling antimicrobial resistance One of the biggest global challenges facing healthcare systems is bacteria and viruses becoming resistant to drugs. Antimicrobial resistance (AMR) contributes to the deaths of around 700,000 people annually. Without… January 24, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 12 May 2023 Achilles Therapeutics’ new platform identifies most potent T-cell antigens Achilles Therapeutics plc says its newly-developed AI application, trained with proprietary real-world data, outperformed current AI and non-AI methods for neoantigen immunogenicity prediction in a recent analysis, enabling the identification… May 12, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 1 Feb 2023 Advancing cancer care with 3D genomics By Oxford BioDynamics Cancer care is in urgent need of effective tests to determine the best approach for personalized medicine. Practical, new solutions exploiting the power of 3D genomics are… February 1, 2023 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 27 Feb 2024 Japan’s ten hottest biotech companies in healthcare …in phase 3 clinical trials in the United States, and grapiprant for cancer and pain management, which is in phase I clinical trials in China and the United States. Additionally,… February 27, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 21 Feb 2023 FDA approves alpha-mannosidosis drug …enzyme α-mannosidase. “Today’s approval of Lamzede represents a major milestone for people living with alpha-mannosidosis. Lamzede is the first and only enzyme replacement therapy approved for alpha-mannosidosis in the United… February 21, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 5 Sep 2022 First patient with peripheral T cell lymphoma dosed with Yingli Pharma’s linperlisib …centers in the United States and Italy. Michael Hui, MBA, chief executive officer of Yingli Pharma, said: “We are pleased to commence this study of linperlisib in the United States in patients suffering… September 5, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email